Crossmark

Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure

Published Online: 2019-08-22

Published Print: 2019-11

Authors

Baker, Joshua C.

Fintelmann, Robert

Sharifi, Roohollah

Lee, Mary https://orcid.org/0000-0002-2584-2736
License Information

Text and Data Mining valid from 2019-08-22

Version of Record valid from 2019-08-22
More Information

Article History

First Online: 22 August 2019

Compliance with Ethical Standards

:

: Joshua C. Baker, Robert Fintelmann, Roohollah Sharifi, and Mary Lee declare no conflicts of interest in the preparation or submission of this manuscript to Drugs and Aging for publication.

: No funding was received by any of the authors in the preparation or submission of this manuscript.

Document is current